-
1
-
-
0030292755
-
Comparison of two estradiol transdermal systems (OESCLIM® 50, ESTRADERM TTS® 50) I. Tolerability, adhesion and efficacy
-
Rozenbaum H, Birkhaüser M, De Nooyer C, et al. Comparison of two estradiol transdermal systems (OESCLIM® 50, ESTRADERM TTS® 50) I. Tolerability, adhesion and efficacy. Maturitas 1996;25:161-73.
-
(1996)
Maturitas
, vol.25
, pp. 161-173
-
-
Rozenbaum, H.1
Birkhaüser, M.2
De Nooyer, C.3
-
2
-
-
0029844969
-
Estrogen replacement therapy and risk of Alzheimer's Disease
-
Paganini-Hill A, Henderson VW. Estrogen replacement therapy and risk of Alzheimer's Disease. Arch Intern Med 1996;156:2213-7.
-
(1996)
Arch Intern Med
, vol.156
, pp. 2213-2217
-
-
Paganini-Hill, A.1
Henderson, V.W.2
-
4
-
-
0029952758
-
What do women want?
-
Mattson LA. What do women want? Brit J Obstet Gynaecol 1996;103(suppl 13):104-107.
-
(1996)
Brit J Obstet Gynaecol
, vol.103
, Issue.13 SUPPL.
, pp. 104-107
-
-
Mattson, L.A.1
-
5
-
-
0002737314
-
A Study to examine women's knowledge, perception and acceptability of hormone replacement therapy
-
Okon MA, Lee S, Li TC. A Study to examine women's knowledge, perception and acceptability of hormone replacement therapy. Eur Menop J 1996;3(2):47-52.
-
(1996)
Eur Menop J
, vol.3
, Issue.2
, pp. 47-52
-
-
Okon, M.A.1
Lee, S.2
Li, T.C.3
-
6
-
-
0021828824
-
The behaviour of endometrial hyperplasia. A long-term study of 'untreated' hyperplasia in 170 patients
-
Kurman RJ, Kaminsi P, Norris HJ. The behaviour of endometrial hyperplasia. A long-term study of 'untreated' hyperplasia in 170 patients. Cancer 1985;56(2):403-12.
-
(1985)
Cancer
, vol.56
, Issue.2
, pp. 403-412
-
-
Kurman, R.J.1
Kaminsi, P.2
Norris, H.J.3
-
7
-
-
0028809308
-
Hormone replacement therapy and endometrial cancer risk: A metaanalysis
-
Grady D, Gebretsadik T, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: A metaanalysis. Obstet Gynecol 1995;85:304-13.
-
(1995)
Obstet Gynecol
, vol.85
, pp. 304-313
-
-
Grady, D.1
Gebretsadik, T.2
Ernster, V.3
Petitti, D.4
-
8
-
-
0002244103
-
Postmenopausal hormone replacement therapy and cancer of the female genital tract and breast
-
Burger CW, Koomen I, Peters NAJB, Van Leeuwen FE, Kenemans P. Postmenopausal hormone replacement therapy and cancer of the female genital tract and breast. Eur Menop J 1997;4(1):23-36.
-
(1997)
Eur Menop J
, vol.4
, Issue.1
, pp. 23-36
-
-
Burger, C.W.1
Koomen, I.2
Peters, N.A.J.B.3
Van Leeuwen, F.E.4
Kenemans, P.5
-
9
-
-
0025742668
-
Progestogen supplementation of exogenous estrogens and the risk of endometrial cancer
-
Voigt LF, Weiss NS, Chi J, Daling JR, McKnight B, van Belle G. Progestogen supplementation of exogenous estrogens and the risk of endometrial cancer. Lancet 1991;338:274-7.
-
(1991)
Lancet
, vol.338
, pp. 274-277
-
-
Voigt, L.F.1
Weiss, N.S.2
Chi, J.3
Daling, J.R.4
McKnight, B.5
Van Belle, G.6
-
10
-
-
0344973789
-
Fact Sheet
-
March
-
American Association for Cancer Research. Fact Sheet. Colorectal Cancer. March 1998.
-
(1998)
Colorectal Cancer
-
-
-
11
-
-
0032079867
-
Postmenopausal hormone use and risk of colorectal cancer and adenoma
-
Grodstein F, Martinez ME, Platz EA, et al. Postmenopausal hormone use and risk of colorectal cancer and adenoma. Ann Intern Med 1998;128:705-12.
-
(1998)
Ann Intern Med
, vol.128
, pp. 705-712
-
-
Grodstein, F.1
Martinez, M.E.2
Platz, E.A.3
-
12
-
-
0344111251
-
Fact Sheet
-
March
-
American Association for Cancer Research. Fact Sheet. Ovarian Cancer. March 1998.
-
(1998)
Ovarian Cancer
-
-
-
13
-
-
0028949915
-
Estrogen replacement therapy and fatal ovarian cancer
-
Rodriguez C, Calle EE, Coates RJ, Miracle-McMahill HL, Thun MJ, Heath CW. Estrogen replacement therapy and fatal ovarian cancer. Am J Epidemiol 1995;141:828-35.
-
(1995)
Am J Epidemiol
, vol.141
, pp. 828-835
-
-
Rodriguez, C.1
Calle, E.E.2
Coates, R.J.3
Miracle-McMahill, H.L.4
Thun, M.J.5
Heath, C.W.6
-
14
-
-
0024424291
-
Risk factors for ovarian cancer: A case-control study
-
Booth M, Beral V, Smith P. Risk factors for ovarian cancer: a case-control study. Br J Cancer 1989;60:592-8.
-
(1989)
Br J Cancer
, vol.60
, pp. 592-598
-
-
Booth, M.1
Beral, V.2
Smith, P.3
-
15
-
-
0027092659
-
The Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women
-
Whittemore AS, Harris R, Itnyre J. The Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992; 136:1184-1203.
-
(1992)
Am J Epidemiol
, vol.136
, pp. 1184-1203
-
-
Whittemore, A.S.1
Harris, R.2
Itnyre, J.3
-
16
-
-
0024832019
-
Noncontraceptive estrogen use and epithelial ovarian cancer
-
Kaufman DW, Kelly JP, Welch WR, et al. Noncontraceptive estrogen use and epithelial ovarian cancer. Am J Epidemiol 1989;130(6):1142-51.
-
(1989)
Am J Epidemiol
, vol.130
, Issue.6
, pp. 1142-1151
-
-
Kaufman, D.W.1
Kelly, J.P.2
Welch, W.R.3
-
17
-
-
0008150747
-
Oestrogen substitution in der Postmenopause vor und nach behandeltem Genitalund Mammakarzinom
-
Lauritzen C, editor. Basel: Aesopus Verlag
-
Lauritzen C. Oestrogen substitution in der Postmenopause vor und nach behandeltem Genitalund Mammakarzinom, In: Lauritzen C, editor. Menopause. Hormonsubstitution heute. Basel: Aesopus Verlag, 1993. pp. 76-88.
-
(1993)
Menopause. Hormonsubstitution Heute
, pp. 76-88
-
-
Lauritzen, C.1
-
18
-
-
0344973788
-
-
A fact sheet for the American Association for Cancer Research: Breast Cancer. Atlanta: American Cancer Society, March
-
American Cancer Society. Recent progress and future opportunities in cancer research. A fact sheet for the American Association for Cancer Research: Breast Cancer. Atlanta: American Cancer Society, March 1998.
-
(1998)
Recent Progress and Future Opportunities in Cancer Research
-
-
-
19
-
-
0002682488
-
Breast cancer: Reducing mortality through early detection
-
Clinicians Publishing Group and Williams and Wilkins Medscape online
-
White GL Jr, Griffith CJ, Nenstiel RO, Dyess DL. Breast cancer: Reducing mortality through early detection, In: Clinicians Reviews 6(9). Clinicians Publishing Group and Williams and Wilkins. Medscape online, pp. 77-106.
-
Clinicians Reviews
, vol.6
, Issue.9
, pp. 77-106
-
-
White G.L., Jr.1
Griffith, C.J.2
Nenstiel, R.O.3
Dyess, D.L.4
-
20
-
-
0030793213
-
Breast cancer epidemiology and risk factors
-
Broeders MJM, Verbeek ALM. Breast cancer epidemiology and risk factors. QJ Nucl Med 1997;41:179-88.
-
(1997)
QJ Nucl Med
, vol.41
, pp. 179-188
-
-
Broeders, M.J.M.1
Verbeek, A.L.M.2
-
21
-
-
0028099549
-
Epidemiology, prevention and early detection of breast cancer
-
Helzlsouer KJ. Epidemiology, prevention and early detection of breast cancer. Curr Opin Oncol 1994;6:541-8.
-
(1994)
Curr Opin Oncol
, vol.6
, pp. 541-548
-
-
Helzlsouer, K.J.1
-
23
-
-
0028037901
-
Breast cancer trends incidence, mortality and survival
-
Sondik RJ. Breast cancer trends incidence, mortality and survival. Cancer 1994;74:995-9.
-
(1994)
Cancer
, vol.74
, pp. 995-999
-
-
Sondik, R.J.1
-
24
-
-
0027182529
-
Endogenous hormones and breast cancer risk
-
Berstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993;15:38-65.
-
(1993)
Epidemiol Rev
, vol.15
, pp. 38-65
-
-
Berstein, L.1
Ross, R.K.2
-
25
-
-
0028113345
-
Isolation of BRCA1, the 17 q-linked breast and ovarian cancer susceptibility gene
-
Miki Y, Swensen J, Shattuck-Eidens D, et al. Isolation of BRCA1, the 17 q-linked breast and ovarian cancer susceptibility gene. Science 1994;266:66-71.
-
(1994)
Science
, vol.266
, pp. 66-71
-
-
Miki, Y.1
Swensen, J.2
Shattuck-Eidens, D.3
-
26
-
-
0028006563
-
Localisation of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13
-
Wooster R, Neuhausen SL, Mangion Y, et al. Localisation of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994;265:2088-90.
-
(1994)
Science
, vol.265
, pp. 2088-2090
-
-
Wooster, R.1
Neuhausen, S.L.2
Mangion, Y.3
-
27
-
-
0027394970
-
Hormone therapy following breast and uterine cancer
-
Wren BG. Hormone therapy following breast and uterine cancer. Baillières Clin Endocrinol Metab 1993;7(1):225-42.
-
(1993)
Baillières Clin Endocrinol Metab
, vol.7
, Issue.1
, pp. 225-242
-
-
Wren, B.G.1
-
28
-
-
0025293539
-
Progestin regulation of cellular proliferation
-
Clarke CL, Sutherland RL. Progestin regulation of cellular proliferation. Endocr Rev 1990;11:266-301.
-
(1990)
Endocr Rev
, vol.11
, pp. 266-301
-
-
Clarke, C.L.1
Sutherland, R.L.2
-
29
-
-
0026341121
-
Estrogen replacement therapy and the risk of breast cancer: Results from the case-control surveillance study
-
Kaufman DW, Palmer JR, de Mouzon J, et al. Estrogen replacement therapy and the risk of breast cancer: Results from the case-control surveillance study. Am J Epidemiol 1991;134:1375-85.
-
(1991)
Am J Epidemiol
, vol.134
, pp. 1375-1385
-
-
Kaufman, D.W.1
Palmer, J.R.2
De Mouzon, J.3
-
30
-
-
0026706616
-
Non-contraceptive hormone use and risk of breast cancer
-
Yang CP, Daling JR, Band PR, et al. Non-contraceptive hormone use and risk of breast cancer. Cancer Causes Control 1992;3:475-9.
-
(1992)
Cancer Causes Control
, vol.3
, pp. 475-479
-
-
Yang, C.P.1
Daling, J.R.2
Band, P.R.3
-
31
-
-
0027266756
-
Hormone replacement therapy and risk of breast cancer: Results from epidemiologic studies
-
Colditz GA, Egan KM, Stampfer MJ. Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. Am J Obstet Gynecol 1993;168:1473-80.
-
(1993)
Am J Obstet Gynecol
, vol.168
, pp. 1473-1480
-
-
Colditz, G.A.1
Egan, K.M.2
Stampfer, M.J.3
-
32
-
-
0026458371
-
Hormone therapy to prevent disease and prolong life in postmenopausal women
-
Grady D, Rubin S, Petitti D, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-37.
-
(1992)
Ann Intern Med
, vol.117
, pp. 1016-1037
-
-
Grady, D.1
Rubin, S.2
Petitti, D.3
-
33
-
-
0030843969
-
Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
-
(Oct 11).
-
Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047-1059 (Oct 11).
-
(1997)
Lancet
, vol.350
, pp. 1047-1059
-
-
-
34
-
-
0029056755
-
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women
-
Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-93.
-
(1995)
N Engl J Med
, vol.332
, pp. 1589-1593
-
-
Colditz, G.A.1
Hankinson, S.E.2
Hunter, D.J.3
-
35
-
-
85044683407
-
Hormone Replacement Therapy, Drug Therapeut
-
Hormone Replacement Therapy, Drug Therapeut. Bull. 1996;34(11):81-84.
-
(1996)
Bull.
, vol.34
, Issue.11
, pp. 81-84
-
-
-
36
-
-
0027425782
-
Gynecologic complications of cyclic estrogen progestin therapy
-
Ettinger B, Selby JV, Citron JT, Ettinger VM, Zhang D. Gynecologic complications of cyclic estrogen progestin therapy. Maturitas 1993;17:197-204.
-
(1993)
Maturitas
, vol.17
, pp. 197-204
-
-
Ettinger, B.1
Selby, J.V.2
Citron, J.T.3
Ettinger, V.M.4
Zhang, D.5
-
38
-
-
0002435541
-
The high risk of CHD for women: Understanding why prevention is crucial
-
Wenger N. The high risk of CHD for women: understanding why prevention is crucial, Medscape Women's Health 1996;1(11):6.
-
(1996)
Medscape Women's Health
, vol.1
, Issue.11
, pp. 6
-
-
Wenger, N.1
-
39
-
-
0026600502
-
HRT: An analysis of benefits, risks and costs
-
Daly E, Roche M, Barlow D, Gray A, McPherson K, Vessey M. HRT: An analysis of benefits, risks and costs. Br Med Bull 1992;48(2):368-400.
-
(1992)
Br Med Bull
, vol.48
, Issue.2
, pp. 368-400
-
-
Daly, E.1
Roche, M.2
Barlow, D.3
Gray, A.4
McPherson, K.5
Vessey, M.6
-
40
-
-
0005439927
-
Osteoporosis: Unmasking the silent epidemic
-
Kushner P. Osteoporosis: Unmasking the silent epidemic. Hospital Med 1998;34(5):25-39.
-
(1998)
Hospital Med
, vol.34
, Issue.5
, pp. 25-39
-
-
Kushner, P.1
|